1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Director Resignation - David Lazar Steps Down from KALA BIO, Inc. Board
CEO Resignation; David Lazar Steps Down at KALA Bio, Inc.
KALA Bio Enters into $6 Million Series AA Preferred Stock Agreement
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
KALA BIO, Inc. Enters At The Market Offering Agreement with Wainwright
Settles Approximately $10.6 Million of Debt
Other Events
Material disclosure
Notice of Late Filing for Annual Report
Q3
Notice of Late Filing for Quarterly Report
Q2
Q1
FY 2024
Notice of Exempt Offering of Securities
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRER14A
PRE 14A
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership